Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Konrad Isernhagen"'
Autor:
Claus Niederau, Stefan Mauss, Andreas Schober, Albrecht Stoehr, Tim Zimmermann, Michael Waizmann, Gero Moog, Stefan Pape, Bernd Weber, Konrad Isernhagen, Petra Sandow, Bernd Bokemeyer, Ulrich Alshuth, Hermann Steffens, Dietrich Hüppe
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e107592 (2014)
BackgroundPrevious trials have often defined genotype 2 and 3 patients as an "easy to treat" group and guidelines recommend similar management.AimsThe present study looks for differences between the two genotypes and analyzes predictive factors for S
Externí odkaz:
https://doaj.org/article/7d1f2f83d9d84eda81a49ca51c12a914
Autor:
Konrad Isernhagen, Felix Braun, Ulrich W. Preuss, Christian P. Strassburg, Georg Schomerus, Daniela Daute-Weiser
Publikováno v:
SUCHT. 64:157-164
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b931f6a3b1f2e296112b6c13fab6407
https://doi.org/10.1024/0939-5911/a000540
https://doi.org/10.1024/0939-5911/a000540
Autor:
Bernd Schulte, Sabine Schütt, Jochen Brack, Peter Deibler, Jens Reimer, Uwe Verthein, Konrad Isernhagen, Christian Haasen, Christoph Dilg
Publikováno v:
Drug and Alcohol Dependence. 109:248-251
Severely opioid-dependent patients are at high risk of both acquiring and spreading the hepatitis C virus (HCV). It is uncertain, however, whether these patients are possible candidates for HCV treatment. We therefore explored treatment retention and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9aa784c02c683c96810ba75a8d13282
https://doi.org/10.1016/j.drugalcdep.2010.01.009
https://doi.org/10.1016/j.drugalcdep.2010.01.009
Autor:
Eckart Struck, Konrad Isernhagen
Publikováno v:
Suchttherapie. 3:211-218
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9fb794a71b5cbf105d54dcc175d39b0
https://doi.org/10.1055/s-2002-36179
https://doi.org/10.1055/s-2002-36179
Autor:
Hermann Steffens, Stefan Mauss, Bernd Weber, Claus Niederau, Petra Sandow, Tim Zimmermann, Albrecht Stoehr, Bernd Bokemeyer, Andreas Schober, Gero Moog, Stefan Pape, Ulrich Alshuth, Dietrich Hüppe, Konrad Isernhagen, Michael Waizmann
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 9, p e107592 (2014)
PLoS ONE, Vol 9, Iss 9, p e107592 (2014)
BackgroundPrevious trials have often defined genotype 2 and 3 patients as an "easy to treat" group and guidelines recommend similar management.AimsThe present study looks for differences between the two genotypes and analyzes predictive factors for S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b537fd98885c505143c303561e1f0cf1
https://pubmed.ncbi.nlm.nih.gov/25238535
https://pubmed.ncbi.nlm.nih.gov/25238535
Autor:
U Naumann, Michael Waizmann, Stefan A. Racky, Bernd Bokemeyer, Heribert Knechten, Dietrich Hüppe, Christoph Eisenbach, Konrad Isernhagen, Hermann Steffens, Stefan Pape, Stefan Mauss, Ulrich Alshuth, Martin Rössle, Peter Buggisch, Hanns F. Löhr, Joachim Haessner
Publikováno v:
Gastroenterology. 142:S-957
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac8860daecea5c8ed83cfeb008b51e26
https://doi.org/10.1016/s0016-5085(12)63711-1
https://doi.org/10.1016/s0016-5085(12)63711-1